Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting
SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta is invited to participate the 10th TEMTIA meeting in Paris, France, November 7 to 10 and present preclinical data of TST003, Transcenta's first-in-class, high affinity humanized...
United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World’s First Total-Body PET/CT
To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congress from October 15-19, 2022, in Barcelona with its groundbreaking PET/CT, uEXPLORER. As the sponsor...
Prenatal Genetic Testing Market to Improve Accuracy Through Technological Advances
Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, says Frost & Sullivan SAN ANTONIO, Oct. 24, 2022 /PRNewswire/ -- Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, according to Frost & Sullivan's recent analysis, Global Prenatal Genetic Testing Industry. Physicians' emphasis on tests for children and parents...
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities
WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP HANGZHOU, China, Oct. 24, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced its new drug product (DP) facility – named DP8...
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
GAITHERSBURG, Md., Oct. 22, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a first...
Advanced Instruments Introduces the OsmoPRO® MAX Automated Osmometer to Maximize Clinical Lab Productivity
Our newest osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. NORWOOD, Mass., Oct. 22, 2022 /PRNewswire/ -- Recently, Advanced Instruments announced the newest addition to its clinical line of freezing point osmometers, the...
Antengene Announces XPOVIO® Regulatory Approval in Taiwan for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma
- XPOVIO® is the first and only exportin 1 (XPO1) inhibitor approved in Taiwan - Antengene plans to submit for national health insurance reimbursement in Taiwan for XPOVIO® in Q4 2022 SHANGHAI and HONG KONG, Oct. 21, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering,...
SIRONA completes enrollment – A leap in the DCB treatment of femoropopliteal arterial disease
TAMPA, Fla., Oct. 21, 2022 /PRNewswire/ -- Concept Medical Inc. announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA – Concept Medical Inc.) V/S Paclitaxel DCB angioplasty for the treatment of peripheral artery disease in...
SK bioscience Appoints New Executives towards Global Business Growth
Global experts continue to join SK bioscience, while its U.S. corporate entity is being established Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness SEOUL, South Korea, Oct. 21, 2022 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the...
AFTER 30 YEARS — NEW GUIDELINES FOR WEIGHT-LOSS SURGERY
Medical Groups Replace Outdated Consensus Statement that Overly Restricts Access to Modern-Day Weight-Loss Surgery NEWBERRY, Fla., Oct. 21, 2022 /PRNewswire/ -- Two of the world's leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse metabolic surgery for patients with type 2 diabetes...
